Site icon Duncan Bucknell

Pharma & Biotech GWiR 9 January 2009 from IP Think Tank

Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/

 
Highlights this week included:

Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks’ Patent Infringement Updates) (Patent Baristas)

Sprycel (Dasatinib) – India: Delhi High Court orders Indian Drug Controller to ‘police’ patents in Dastinib case between Bristol Myers Squibb and Hetero (Spicy IP)

Zovirax (Aciclovir) – EU: ECJ decides on reference from Austria regarding repackaging: The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH (IPKat) (Class 46)

 
General

Brazil: Uncertainty over patents casts a shadow over Brazil pharma sector (IP tango)

Ethiopia: BIO-EARN invests in Ethiopia (Afro-IP)

Germany: SPC Blog Patent Office tour – supplementary protection certificates (The SPC Blog)

Sweden: SPC Blog Patent Office tour – supplementary protection certificates (The SPC Blog)

UK/US: AstraZeneca may join generic rush (GenericsWeb)

US: Future President Obama and generic drugs and biologics (IP finance)

US: Top biotech and pharma patent stories of 2008 (#13 to #10 – Patent Docs) (#9 to #6 – Patent Docs) (#5 to #1 – Patent Docs)  

US: Teva CEO predicts passage of Follow-on Biologics Bill in 2009 (Patent Docs)

US: Biotechnology Industry Organization sends open letter to President-Elect Obama on patent reform (Patent Barristas) (Patent Docs)

US: Biotechnology Industry Organization says CBO estimate of follow-on biologics savings is based on ‘troubling assumption’ (Patent Docs)

US: In re Kubin to be argued before Federal Circuit Thursday 8 Jan (Patent Docs) (Hal Wegner)

US: Pfizer ordered to pay $39M in trade secrets dispute (Law360)

US: Federal judge gives final approval to $33M settlement of antitrust lawsuit alleging Hoffmann-La Roche and others exploited patent useful to analysing DNA samples (Law360)

US: Federal judge rules court lacks personal jurisdiction over Vanderbilt in patent suit filed by Invitrogen seeking declaration of non-infringement over recombinant protein technology (Law360)

 
Products

Amrix (Cyclobenzaprine) – US: Cephalon files patent infringement suit against Impax to block generic Amrix (Law360)

Boniva (Ibandronic acid) – US: Hoffmann-La Roche drops patent from lawsuits seeking to block a generic Boniva (Law360)

Clarinex (Desloratadine) – US: Schering, Sepracor, Dr Reddy’s strike settlement deals that should allow Dr Reddy’s to enter US Clarinex market in 2012 (Law360)

Femcon Fe (Norethindrone, Ethinyl estradiol, Ferrous fumarate) – US: Barr, Warner Chilcott settle Femcon Fe patent suit (Law360)

Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks’ Patent Infringement Updates) (Patent Baristas)

Miralax (Polyethelene glycol) – US: Generic ANDA applicant seeks antitrust damages where Braintree had purchased patent blocking generic entry of drug competition: Braintree Laboratories, Inc v Schwarz Pharma, Inc (Hal Wegner)

Mirapex (Pramipexole) – US: Boehringer appeals from judgment that Mirapex patent claims are invalid for nonstatutory double patenting: Boehringer Ingelheim v Barr Labs (PATracer)

Prilosec (Omeprazole magnesium) – US: PTO denies patent term extension for Prilosec; Symbicort patent term extension decision likely to follow suit; litigation seems a likely possibility (FDA Law Blog)

Pulmicort respules (Budesonide) – US: AstraZeneca settles US patent litigation with Teva (The IP Factor)

Soliris (Eculizamab) – US: Alexion to pay PDL BioPharma $25M as part of licensing deal resolving patent infringement suit over Soliris (Law360)

Sprycel (Dasatinib) – India: Delhi High Court orders Indian Drug Controller to ‘police’ patents in Dastinib case between Bristol Myers Squibb and Hetero (Spicy IP)

Strovite Advance – US: Breckenridge challenges patent and copyright related to Everett Laboratories’ Strovite Advance prescription vitamin supplement, on the same day it releases competing product Nutravance (Law360)

Treximet (Sumatripan, Naproxen) – US: Pozen files patent infringement suit against Alphapharm, Mylan over generic Treximet (Law360)

Zovirax (Aciclovir) – EU: ECJ decides on reference from Austria regarding repackaging: The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH (IPKat) (Class 46)

 

Exit mobile version